IL76877A - Diagnostic method for the determination of human non-small cell lung carcinomas employing novel monoclonal antibodies and compositions containing said antibodies - Google Patents
Diagnostic method for the determination of human non-small cell lung carcinomas employing novel monoclonal antibodies and compositions containing said antibodiesInfo
- Publication number
- IL76877A IL76877A IL76877A IL7687785A IL76877A IL 76877 A IL76877 A IL 76877A IL 76877 A IL76877 A IL 76877A IL 7687785 A IL7687785 A IL 7687785A IL 76877 A IL76877 A IL 76877A
- Authority
- IL
- Israel
- Prior art keywords
- antibodies
- small cell
- cell lung
- determination
- human non
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 208000002154 non-small cell lung carcinoma Diseases 0.000 title abstract 2
- 238000002405 diagnostic procedure Methods 0.000 title 1
- 125000003563 glycoside group Chemical group 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 125000005629 sialic acid group Chemical group 0.000 abstract 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3023—Lung
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
- Y10S530/864—Monoclonal
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66752184A | 1984-11-02 | 1984-11-02 | |
| US78517785A | 1985-10-07 | 1985-10-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL76877A0 IL76877A0 (en) | 1986-02-28 |
| IL76877A true IL76877A (en) | 1991-11-21 |
Family
ID=27099700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL76877A IL76877A (en) | 1984-11-02 | 1985-10-29 | Diagnostic method for the determination of human non-small cell lung carcinomas employing novel monoclonal antibodies and compositions containing said antibodies |
Country Status (21)
| Country | Link |
|---|---|
| EP (2) | EP0207090B1 (da) |
| JP (3) | JPH0675514B2 (da) |
| KR (1) | KR910000903B1 (da) |
| AT (1) | ATE117089T1 (da) |
| AU (1) | AU599578B2 (da) |
| DE (1) | DE3587976T2 (da) |
| DK (1) | DK170619B1 (da) |
| ES (1) | ES8704735A1 (da) |
| FI (1) | FI85814C (da) |
| GB (1) | GB2182949B (da) |
| GR (1) | GR852622B (da) |
| HU (1) | HU208546B (da) |
| IE (1) | IE58590B1 (da) |
| IL (1) | IL76877A (da) |
| NO (1) | NO862690D0 (da) |
| NZ (1) | NZ214055A (da) |
| OA (1) | OA08354A (da) |
| PH (1) | PH24961A (da) |
| PT (1) | PT81418B (da) |
| WO (1) | WO1986002735A1 (da) |
| YU (1) | YU46386B (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4708930A (en) * | 1984-11-09 | 1987-11-24 | Coulter Corporation | Monoclonal antibody to a human carcinoma tumor associated antigen |
| US4906562A (en) * | 1984-12-21 | 1990-03-06 | Oncogen | Monocolonal antibodies and antigen for human non-small cell lung carcinomas |
| JPS61258173A (ja) * | 1985-05-10 | 1986-11-15 | Akira Taniuchi | モノクロ−ナル抗体およびその製法ならびに用途 |
| AU601680B2 (en) * | 1985-05-28 | 1990-09-20 | Joseph P. Brown | Monoclonal antibodies for human non-small cell lung carcinomas |
| US5185432A (en) * | 1986-02-26 | 1993-02-09 | Oncogen | Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas |
| JPS6319561A (ja) * | 1986-07-11 | 1988-01-27 | Kyowa Hakko Kogyo Co Ltd | 抗ヒト肺癌単クロ−ン性抗体 |
| US6004761A (en) * | 1986-11-19 | 1999-12-21 | Sanofi | Method for detecting cancer using monoclonal antibodies to new mucin epitopes |
| NZ222509A (en) * | 1986-11-19 | 1993-03-26 | Oncogen | Hybridoma cell line producing antibodies binding to tumour-associated mucin antigen |
| CA1340221C (en) * | 1988-01-29 | 1998-12-15 | Thomas Frank Bumol | Vectors, compounds and method for expression of a human adenocarcinoma antigen |
| AU632469B2 (en) * | 1988-04-04 | 1993-01-07 | Johns Hopkins University, The | A method for early detection of lung cancer |
| US5171665A (en) * | 1989-04-17 | 1992-12-15 | Oncogen | Monoclonal antibody to novel antigen associated with human tumors |
| IT1254309B (it) * | 1992-02-17 | 1995-09-14 | Uni Degli Studi G D Annunzio C | Sequenze genetiche per l'antigene 90k associato a tumori. |
| IT1264490B (it) * | 1992-02-17 | 1996-09-24 | Uni Degli Studi G D Annunzio C | Antigene 90k associato a tumori. |
| JPH0727604U (ja) * | 1993-06-18 | 1995-05-23 | 修司 坂本 | 磁気治療具 |
| EP0695760A1 (en) * | 1994-08-05 | 1996-02-07 | F. Hoffmann-La Roche Ag | Novel tumor marker for lung cancer |
| DE202012001863U1 (de) | 2012-02-22 | 2012-03-19 | Haldex Brake Products Ab | Scheibenbremse und Sensoreinrichtung hierfür |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4172124A (en) * | 1978-04-28 | 1979-10-23 | The Wistar Institute | Method of producing tumor antibodies |
| US4906562A (en) * | 1984-12-21 | 1990-03-06 | Oncogen | Monocolonal antibodies and antigen for human non-small cell lung carcinomas |
| JPS61258173A (ja) * | 1985-05-10 | 1986-11-15 | Akira Taniuchi | モノクロ−ナル抗体およびその製法ならびに用途 |
| AU601680B2 (en) * | 1985-05-28 | 1990-09-20 | Joseph P. Brown | Monoclonal antibodies for human non-small cell lung carcinomas |
-
1985
- 1985-10-29 IL IL76877A patent/IL76877A/xx not_active IP Right Cessation
- 1985-10-30 PH PH32994A patent/PH24961A/en unknown
- 1985-10-30 GB GB8616219A patent/GB2182949B/en not_active Expired
- 1985-10-30 KR KR1019860700419A patent/KR910000903B1/ko not_active IP Right Cessation
- 1985-10-30 JP JP60505034A patent/JPH0675514B2/ja not_active Expired - Lifetime
- 1985-10-30 EP EP85905694A patent/EP0207090B1/en not_active Expired - Lifetime
- 1985-10-30 AT AT85905694T patent/ATE117089T1/de not_active IP Right Cessation
- 1985-10-30 EP EP19930106003 patent/EP0566066A1/en not_active Withdrawn
- 1985-10-30 WO PCT/US1985/002132 patent/WO1986002735A1/en active IP Right Grant
- 1985-10-30 AU AU50691/85A patent/AU599578B2/en not_active Ceased
- 1985-10-30 HU HU86549A patent/HU208546B/hu not_active IP Right Cessation
- 1985-10-30 DE DE3587976T patent/DE3587976T2/de not_active Expired - Fee Related
- 1985-10-31 PT PT81418A patent/PT81418B/pt not_active IP Right Cessation
- 1985-10-31 ES ES548421A patent/ES8704735A1/es not_active Expired
- 1985-10-31 GR GR852622A patent/GR852622B/el unknown
- 1985-11-01 IE IE268185A patent/IE58590B1/en not_active IP Right Cessation
- 1985-11-04 YU YU172185A patent/YU46386B/sh unknown
- 1985-11-04 NZ NZ214055A patent/NZ214055A/en unknown
-
1986
- 1986-07-02 NO NO862690A patent/NO862690D0/no unknown
- 1986-07-02 DK DK314586A patent/DK170619B1/da not_active IP Right Cessation
- 1986-07-02 FI FI862821A patent/FI85814C/fi not_active IP Right Cessation
- 1986-07-02 OA OA58895A patent/OA08354A/xx unknown
-
1994
- 1994-01-12 JP JP6001442A patent/JP2567564B2/ja not_active Expired - Lifetime
- 1994-01-12 JP JP6001441A patent/JPH0733400B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL76877A (en) | Diagnostic method for the determination of human non-small cell lung carcinomas employing novel monoclonal antibodies and compositions containing said antibodies | |
| Butkowski et al. | Properties of the globular domain of type IV collagen and its relationship to the Goodpasture antigen. | |
| EP0471011B2 (en) | HUMAN LACTOFERRIN cDNA SEQUENCE | |
| Cameron et al. | Purification to homogeneity and amino acid sequence analysis of two anionic species of human interleukin 1. | |
| Jander et al. | A collagen-like glycoprotein of the extracellular matrix is the undegraded form of type VI collagen | |
| FI102075B1 (fi) | Menetelmä valmistaa glykosyloitu tai glykosyloimaton polypeptidi, rekombinanttinukleiinihappo ja vektorit | |
| CA2032153A1 (fr) | Application de nouveaux fragments d'adn en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant | |
| KR910700257A (ko) | 상피 세포에 특이적인 성장인자를 암호하는 dna | |
| GR861141B (en) | Particles having the immunogenic properties of the hbs antigen and an antigenic side strange to the epitopes of the antigen hbs vectors and animals cells for the production of said particles and compositions containing such particles | |
| DE69132814D1 (de) | Neues insulinähnliches wachstumsfaktor bindendes protein igfbp-5 | |
| ES2007425A6 (es) | Un metodo para la produccion de una proteina con actividad inhibidora del crecimiento de tumores. | |
| KR860002526A (ko) | 단백질의 상호 분리 방법 | |
| Lester et al. | A postsynthetic modification of human α-fetoprotein controls its immunosuppressive potency | |
| Stathakis et al. | Human fibrinogen heterogeneities. Preparation and characterization of γ and γ′ chains | |
| Novak-Hofer et al. | Two-dimensional separation of chloroplast membrane proteins by isoelectri focusing and electrophoresis in sodium dodecyl sulphate | |
| WO1997012044A3 (en) | Pichia secretory leader for protein expression | |
| AUPM772494A0 (en) | Improvements in production of proteins in host cells | |
| Banga et al. | Comparative biochemical analysis of purified S-antigen from human, bovine, porcine and rat retina | |
| Lester et al. | Heterogeneity of human α-fetoprotein as revealed by isoelectric focusing in urea-containing gels | |
| EP0206849A3 (en) | Method for the diagnosis in vitro of malignant cells originating from the digestive duct | |
| EP0750040A3 (en) | Macrophage stimulating protein variant and method for producing the same | |
| Schalekamp et al. | Recombination of embryonic haemoglobin chains during the development of the chick | |
| Alekseeva et al. | Chemical fragmentation by o-iodosobenzoic acid of alpha-chain of histidine decarboxylase from Micrococcus sp. n. AT tryptophan residues. | |
| Obinata et al. | Heterogeneity of low molecular weight epidermal structural proteins of chick embryonic tarsometatarsal skin: effect of hydrocortisone on its accumulation with reference to differentiation of epidermal cells | |
| Mohr et al. | Antibodies to interleukin-2 (IL-2) in patients: cross reactivity with different IL-2 species |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RH | Patent void |